Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Oxidative Medicine and Cellular Longevity|August 8, 2014
Approach to reduction of blood atherogenicityAlexander N Orekhov, Alexandra A Melnichenko, Igor A SobeninTherapeutics and Clinical Risk Management|February 23, 2018
Mitochondrial genome variability: the effect on cellular functional activityAleksandrina S Volobueva, Alexandra A Melnichenko, Andrey V Grechko, et al.Current Drug Targets|October 28, 2017
Engineered Nanoparticles: Their Properties and Putative Applications for Therapeutic Approaches Utilizing Stem Cells for the Repair of Atherosclerotic DiseaseDimitry A Chistiakov, Alexandra A Melnichenko, Alexander N Orekhov, et al.Current Pharmaceutical Design|November 19, 2016
Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Agonists as Therapeutic Agents for Cardiovascular Disorders: Focus on AtherosclerosisEkaterina A Ivanova, Veronika A Myasoedova, Alexandra A Melnichenko, et al.International Journal of Cardiology|January 6, 2017
How do macrophages sense modified low-density lipoproteins?Dimitry A Chistiakov, Alexandra A Melnichenko, Alexander N Orekhov, et al.Biochimie|October 25, 2016
Paraoxonase and atherosclerosis-related cardiovascular diseasesDimitry A Chistiakov, Alexandra A Melnichenko, Alexander N Orekhov, et al.Biomedicines|October 27, 2022
Familial Hypercholesterolaemia as a Predisposing Factor for AtherosclerosisAnastasia V Poznyak, Larisa Litvinova, Paolo Poggio, et al.Biomedicines|July 16, 2020
NLPR3 Inflammasomes and Their Significance for AtherosclerosisAnastasia V Poznyak, Alexandra A Melnichenko, Reinhard Wetzker, et al.Journal of Molecular Medicine (Berlin, Germany)|August 9, 2017
Mechanisms of foam cell formation in atherosclerosisDimitry A Chistiakov, Alexandra A Melnichenko, Veronika A Myasoedova, et al.International Journal of Molecular Sciences|July 18, 2017
Thrombospondins: A Role in Cardiovascular DiseaseDimitry A Chistiakov, Alexandra A Melnichenko, Veronika A Myasoedova, et al.Pageof 5